Shutdown Threat Clouds Start of Biden Drug-Pricing Negotiations

A potential government shutdown at the end of the month risks complicating the Biden administration’s top health priorities, just as drugmakers are supposed to report data for pricing negotiations and states are pushing people off Medicaid rolls.

Federal agencies will face a lapse in funding Oct. 1 should Congress fail to pass appropriations legislation or a short-term, stopgap measure. Lawmakers are divided over a spending plan for fiscal 2024.

A shutdown would bump up against an Oct. 2 deadline for some drugmakers to report a slew of data to Medicare as part of how the agency will eventually determine new ...